AbbVie dividend and valuation
Valuation
AbbVie paid $6.92 per share in dividends over the last 12 months (yield 2.4%). Next ex-dividend date: January 15, 2027. The P/E ratio is 50.4. The average price target of 26 analysts is $314.12.
What would AbbVie's dividends pay over 10 years? Work it out with the dividend calculator
Data as of November 18, 2026
AbbVie compared with similar companies
AbbVie's P/E (trailing 12 months): 50.4, +20% against the median of a group of 10 similar companies (42.1).
| Metric | AbbVie | Median | 25th–75th percentile | Band |
|---|---|---|---|---|
| P/E (trailing 12 months) | 50.4 | 42.1 | 28.2 – 49.4 | High |
| Forward P/E | 18.1 | 16.8 | 15.8 – 18.5 | Middle |
| EV/EBITDA | 18.5 | 14.8 | 12.8 – 17.5 | High |
| Price/sales | 7.84 | 5.29 | 4.03 – 6.83 | High |
| Gross margin | 73.7% | 74.9% | 73.1% – 75.5% | Middle |
| Operating margin | 36.6% | 34.0% | 30.7% – 35.9% | High |
| Net margin | 15.7% | 16.2% | 5.0% – 19.0% | Middle |
Group: the stock and up to 10 companies in the same industry (with fewer than 5, related industries too), same region first, with a similar size. Band: low = the lowest quarter of values in the group, middle = 25th to 75th percentile, high = the highest quarter. Negative multiples and multiples above 500 are excluded; a comparison needs at least 5 values. The group is recalculated nightly.
TickerLandia analysisHow it is calculated
Companies in the group: same industry, similar size
AbbVie: valuation over time
On the latest fiscal year's earnings (2025), AbbVie's P/E today is 124.0, above the median of its last 10 fiscal years (27.2; between 16.8 and 96.8 from 2016 to 2025). Relative to earnings, the stock costs more than it used to. The dividend yield (2.4%) is below the median of the last 10 fiscal years (3.8%).
| Fiscal year | Price at year end | Earnings per share | P/E | Dividend per share | Yield |
|---|---|---|---|---|---|
| 2025 | $228.49 | $2.36 | 96.8 | $6.65 | 2.9% |
| 2024 | $177.70 | $2.39 | 74.4 | $6.29 | 3.5% |
| 2023 | $154.97 | $2.72 | 57.0 | $5.99 | 3.9% |
| 2022 | $161.61 | $6.63 | 24.4 | $5.71 | 3.5% |
| 2021 | $135.40 | $6.45 | 21.0 | $5.31 | 3.9% |
| 2020 | $107.15 | $2.72 | 39.4 | $4.84 | 4.5% |
| 2019 | $88.54 | $5.28 | 16.8 | $4.39 | 5.0% |
| 2018 | $92.19 | $3.66 | 25.2 | $3.95 | 4.3% |
| 2017 | $96.71 | $3.30 | 29.3 | $2.63 | 2.7% |
| 2016 | $62.62 | $3.63 | 17.3 | $2.35 | 3.8% |
TickerLandia calculation: closing price on the last trading day of the fiscal year divided by diluted earnings per share from the annual report (positive earnings only); yield = dividend per share for the year divided by the same price. Prices adjusted for splits. Today's P/E is today's price divided by the latest fiscal year's earnings per share, so it compares with the years above; today's yield uses dividends over the last 12 months.
TickerLandia analysisHow it is calculated
Other metrics
Valuation multiples
- Market cap
- $517.59B
- Enterprise value
- $588.18B
- PEG
- 0.59
- EV/revenue
- 8.91
Profitability and growth
- ROA
- 10.7%
- ROIC
- 19.7%
- Revenue growth (year over year)
- 10.3%
- Earnings growth (year over year)
- 2,282.1%
Financial health
- Total cash
- $10.77B
- Total debt
- $81.32B
- Current ratio
- 0.87
- Quick ratio
- 0.56
- Altman Z-Score
- 2.39
- Piotroski F-Score
- 7.00
Dividends
- Annual dividend per share
- $6.92
- Dividend yield
- 2.4%
- Payout ratio
- 119.1%
- Ex-dividend date
- January 15, 2027
Analysts and estimates
- Average price target
- $314.12
- Median price target
- $319.50
- High price target
- $350.00
- Low price target
- $237.00
- Analysts with a price target
- 26
- Consensus
- Buy
- Forward EPS
- $16.20
- EPS estimate, current year
- $13.98
Shares and trading
- Beta
- 0.19
- Average volume
- 4.81M
- Shares outstanding
- 1.77B
- Float
- 1.76B
- Institutional ownership
- 77.4%
- Insider ownership
- 0.2%
- Short interest (% of float)
- 1.0%
- Short ratio (days)
- 3.04
